ARCHIVES

New Treatment Approaches for Leukemias Emerging From Early Clinical Trials

This article is from The Cancer Letter archive.

Vol. 27 No. 12 | December 31, 2004

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

ACS Reports Breast Cancer Incidence At All Time High

January 23, 1987

DCPC To Merge Two Programs, Reorganizes Chemoprevention

November 4, 1994

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

Groups Lobby Congress For $5.8 Billion Budget For NCI, Increases For Other Programs

June 18, 2010

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014